These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14989221)

  • 21. Importance of early diagnosis in managing ovarian cancer.
    Dunleavey R
    Nurs Times; 2006 Oct 10-16; 102(41):28-9. PubMed ID: 17059048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-therapy surveillance and after-care in ovarian cancer.
    von Georgi R; Schubert K; Grant P; Münstedt K
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):228-33. PubMed ID: 15140520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viewing ovarian cancer as a "chronic disease": what exactly does this mean?
    Markman M
    Gynecol Oncol; 2006 Feb; 100(2):229-30. PubMed ID: 16226801
    [No Abstract]   [Full Text] [Related]  

  • 24. Carcinoma erysipeloides from ovarian clear-cell carcinoma.
    Lee HC; Chu CY; Hsiao CH
    J Clin Oncol; 2007 Dec; 25(36):5828-30. PubMed ID: 18089882
    [No Abstract]   [Full Text] [Related]  

  • 25. Ovarian cancer.
    Chobanian N; Dietrich CS
    Surg Clin North Am; 2008 Apr; 88(2):285-99, vi. PubMed ID: 18381114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of regular physical examination in the detection of ovarian cancer recurrence.
    Chan KK; Tam KF; Tse KY; Ngan HY
    Gynecol Oncol; 2008 Aug; 110(2):158-61. PubMed ID: 18544459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Late recurrence of malignant tumours 20 years after diagnosis and treatment].
    Chodorowski Z; Sein Anand J; Jassem J; Kopacz A; Kruszewski W; Emerich J; Senkus-Konefka E
    Przegl Lek; 2007; 64(4-5):372-3. PubMed ID: 17724919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The clinical picture of recurrences and metastases of malignant cilioepithelial cysts of the ovaries].
    Vinokurov VL
    Vopr Onkol; 1971; 17(7):31-7. PubMed ID: 5137825
    [No Abstract]   [Full Text] [Related]  

  • 29. The quest for ovarian cancer's Holy Grail: can CA-125 still be the chalice of early detection?
    Karlan BY; McIntosh M
    J Clin Oncol; 2007 Apr; 25(11):1303-4. PubMed ID: 17416848
    [No Abstract]   [Full Text] [Related]  

  • 30. [Follow-up after the treatment of ovarian cancer - really without Ca 125?].
    Freitag P
    Ceska Gynekol; 2012 Dec; 77(6):540-2. PubMed ID: 23521196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive approach to advanced primary and recurrent ovarian cancer: a personal experience.
    Carmignani CP; Sugarbaker PH
    Expert Rev Anticancer Ther; 2004 Jun; 4(3):477-87. PubMed ID: 15161446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage I borderline ovarian tumors.
    Creasman WT; Park R; Norris H; Disaia PJ; Morrow CP; Hreshchyshyn MM
    Obstet Gynecol; 1982 Jan; 59(1):93-6. PubMed ID: 7078855
    [No Abstract]   [Full Text] [Related]  

  • 33. Predictive value of PET-CT imaging versus AGO-scoring in patients planned for cytoreductive surgery in recurrent ovarian cancer.
    Lenhard SM; Burges A; Johnson TR; Kirschenhofer A; Bruns C; Linke R; Friese K
    Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):263-8. PubMed ID: 18614272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent ovarian granulosa cell tumors: clinical and imaging features.
    Rha SE; Oh SN; Jung SE; Lee YJ; Lee AW; Byun JY
    Abdom Imaging; 2008; 33(1):119-25. PubMed ID: 17624570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of systemic therapy in women with recurrent ovarian cancer--development of a national clinical practice guideline.
    Elit L; Zitzelsberger L; Fung-Kee-Fung M; Brouwers M; Graham ID; Browman G; Hoskins P; Lau S; Ghatage P;
    Gynecol Oncol; 2007 Jul; 106(1):181-92. PubMed ID: 17498781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II study.
    Atmaca A; Al-Batran SE; Neumann A; Kolassa Y; Jäger D; Knuth A; Jäger E
    Gynecol Oncol; 2009 Feb; 112(2):384-8. PubMed ID: 19059635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
    Havrilesky LJ; Whitehead CM; Rubatt JM; Cheek RL; Groelke J; He Q; Malinowski DP; Fischer TJ; Berchuck A
    Gynecol Oncol; 2008 Sep; 110(3):374-82. PubMed ID: 18584856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of epithelial ovarian cancer].
    Langmár Z; Csömör S
    Orv Hetil; 2006 Aug; 147(34):1627-32. PubMed ID: 17017677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent ovarian cancer: when and how to treat.
    Hall M; Rustin G
    Curr Oncol Rep; 2011 Dec; 13(6):459-71. PubMed ID: 22045509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and management of epithelial ovarian cancer.
    Bhoola S; Hoskins WJ
    Obstet Gynecol; 2006 Jun; 107(6):1399-410. PubMed ID: 16738170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.